| Phase 4 |
| NCT07221838 |
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia… |
Generalized Myasthenia Gravis |
Recruiting |
| NCT07308574 |
Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS |
aHUS |
Recruiting |
| NCT07010302 |
Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD |
NMOSD |
Not Yet Recruiting |
| Phase 3 |
| NCT07024563 |
Study of Ravulizumab in Pediatric Participants With Primary IgAN |
IgAN |
Recruiting |
| NCT06291376 |
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN) |
Immunoglobulin A Nephropathy |
Recruiting |
| NCT06830798 |
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy… |
Delayed Graft Function |
Recruiting |
| NCT05746559 |
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE |
Chronic Kidney Disease |
Active, Not Recruiting |
| NCT05644561 |
Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric… |
Generalized Myasthenia Gravis |
Active, Not Recruiting |
| NCT05133531 |
A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well… |
Paroxysmal Nocturnal Hemoglobinuria |
Active, Not Recruiting |
| NCT07596784 |
Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized… |
Generalized Myasthenia Gravis |
Not Yet Recruiting |
| NCT07557420 |
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of… |
NMOSD |
Not Yet Recruiting |
| Phase 2 |
| NCT06333652 |
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders |
Preeclampsia |
Recruiting |
| Not specified |
| NCT06967480 |
Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis |
Generalized Myasthenia Gravis |
Recruiting |
| NCT06312644 |
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy |
Ultomiris-exposed Pregnant/ Postpartum |
Recruiting |
| NCT06909253 |
Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis |
Myasthenia Gravis, Generalized |
Recruiting |
| NCT07399730 |
Ravulizumab Outcomes in Polish Patients With aHUS |
Atypical Hemolytic Uremic Syndrome |
Not Yet Recruiting |
| NCT06633536 |
Real-life Treatment Outcomes of Ravulizumab in PNH |
Paroxysmal Nocturnal Haemoglobinuria |
Active, Not Recruiting |